[Anti-hepatitis B vaccination: after the health authorities' decision].
In 1991, the WHO proposed that the antihepatitis B vaccine be included in national vaccination programs. In France, it was decided in 1994 to move on from a selective immunization scheme aimed at high-risk subjects to a general vaccination policy aimed first at adolescents in school and secondly infants. During this period, several cases of demyelinizing diseases after vaccination led to court actions and were magnified in the popular press, interfering with this new vaccination policy. On October 1, 1988, the French Secretary of Health decided to interrupt the school vaccination programs. This decision, taken as a precautionary measure, had some unexpected consequences. As had been feared by the WHO, there was an overall drop in the public's confidence in the vaccine. Health care professionals highly criticized the spectacular nature of the decision and the absence of scientific argumentation. These events lead us to raise a certain number of questions concerning the use of the public press in the management of health information, the notion of medical responsibility, and the rationality of political decisions in public health.
Berger
P
P
Laboratoire de Santé Publique, Faculté de Médecine, Marseille.
Micallef
J
J
Barrau
K
K
Manuel
C
C
Auquier
P
P
D000293:Adolescent; D002648:Child; D005260:Female; D005602:France; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D007115:Immunization Schedule; D008297:Male; D011635:Public Health Administration; D012572:School Health Services; D014611:Vaccination
D017325:Hepatitis B Vaccines